Obinutuzumab
Ibrutinib Plus Bendamustine and Rituximab
Update Venetoclax in CLL
Zanubrutinib
Acalabrutinib
JNCCN: How To Manage Cancer Care During COVID-19 Pandemic
Patient Power
UpToDate
NCCN Guidelines for Patients